Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with primary metal stenting for unresectable malignant distal biliary obstruction
Endoscopy · 2026-08 · 58 (08) · 858-871
DOI: 10.1055/a-2876-1567 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endoscopy, online erschienen am 11.06.2026. Verfasst von Daniel Schmitz und 23 weiteren Autor:innen. Beteiligte Einrichtung: Helios Kliniken Schwerin, Department of Gastroenterology and Infectiology, Germany, Schwerin. Hauptthemen laut MEDLINE: Drainage, Endosonography, Cholestasis, Stents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Unresectable malignant distal biliary obstruction (MDBO) may be treated with endoscopic ultrasound-guided (EUS-BD) or percutaneous transhepatic (PTBD) biliary drainage if endoscopic retrograde cholangiopancreatography fails or is not feasible. This study compared EUS-BD and PTBD using an improved ultrasound-guided method with primary metal stenting. A prospective, longitudinal (follow-up 6 months), nonrandomized, noninferiority (10% margin) trial was conducted. Patients were assigned to centers with high competence in one of the two techniques. The primary end point was technical success, with propensity score matching employed to balance differences. Differences in secondary end points were evaluated with two-sided superiority analyses. 209 patients (mean age 73 years) were enrolled between December 2018 and August 2024 from 14 European centers and were subsequently matched 1:1. Noninferiority of PTBD vs. EUS-BD could not be demonstrated with regard to technical success (91.2% vs. 97.1%; P = 0.17; 95%CI –2.3% to 15.1%). Clinical success (intention-to-treat: 73.5% vs. 55.9%; P = 0.05), procedure time, length of hospital stay, and rate of biliary reintervention within 30 days (0.03 vs. 0.31; P < 0.001) were significantly better in the EUS-BD cohort, driven mainly by EUS-guided choledochoduodenostomy (EUS-CDS). No significant differences were observed in adverse events (grades 1–4) (16.7% vs. 14.5%; P = 0.82), pain score, clinical success (per-protocol), rate of biliary reinterventions within 6 months, or overall survival. EUS-BD, particularly EU-CDS, might be preferred over PTBD in unresectable MDBO owing to better clinical success and a lower biliary reintervention rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Helios Kliniken Schwerin, Department of Gastroenterology and Infectiology, Germany, Schwerin.
- Theresienkrankenhaus and Diako GmbH, Teaching Hospital of Heidelberg University, Department of Gastroenterology, Oncology and Diabetology, Germany, Mannheim.
- Hospital Universitari de Bellvitge, Universitat de Barcelona, Bellvitge Biomedical Research Institute Barcelona, Department of Digestive Diseases, Spain, Barcelona.
- Hospital Universitario de Navarra, Endoscopy Unit, Department of Gastroenterology, Spain, Pamplona.
- Robert Bosch Hospital, Department of Gastroenterology, Hepatology and Endocrinology, Germany, Stuttgart.
- University Hospital Freiburg, Department of Medicine II: Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Germany, Freiburg.
ORCID-Profile: Daniel Schmitz, Joan B Gornals, Juan J Vila, José Ramón Aparicio Tormo, Francisco Javier García-Alonso, Albert Garcia-Sumalla, Armin Kuellmer, Belen Martinez-Moreno, Manuel Perez-Miranda
Zitieren
APA
Schmitz, D., Gornals, J. B., Vila, J. J., Schmidt, A., Kleemann, T., Aparicio Tormo, J. R., Amanzada, A., Dollhopf, M., Redondo-Cerezo, E., Weigt, J., Voigtländer, T., von Hahn, T., Franck, F., García-Alonso, F. J., Schich, M., Garcia-Sumalla, A., Prax, S., Arrubla, A., Kuellmer, A., …, & Perez-Miranda, M. (2026). Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with primary metal stenting for unresectable malignant distal biliary obstruction. Endoscopy, 58(08), 858-871. https://doi.org/10.1055/a-2876-1567
Vancouver
Schmitz D, Gornals JB, Vila JJ, Schmidt A, Kleemann T, Aparicio Tormo JR, et al. Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with primary metal stenting for unresectable malignant distal biliary obstruction. Endoscopy. 2026;58(08):858-871. doi:10.1055/a-2876-1567
BibTeX
@article{Schmitz2026,
author = {Schmitz, Daniel and Gornals, Joan B and Vila, Juan J and Schmidt, Arthur and Kleemann, Tobias and Aparicio Tormo, José Ramón and Amanzada, Ahmad and Dollhopf, Markus and Redondo-Cerezo, Eduardo and Weigt, Jochen and Voigtländer, Torsten and von Hahn, Thomas and Franck, Franziska and García-Alonso, Francisco Javier and Schich, Martin and Garcia-Sumalla, Albert and Prax, Stefan and Arrubla, Amaia and Kuellmer, Armin and Martinez-Moreno, Belen and Grassmann, Felix and Rudi, Jochen and Valiente, Carlos T and Perez-Miranda, Manuel},
title = {Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with primary metal stenting for unresectable malignant distal biliary obstruction},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {08},
pages = {858--871},
doi = {10.1055/a-2876-1567}
}
EUVIMED